Latest News

Lidocaine May Benefit Breast Cancer Survivors Who Experience Dyspareunia

Lidocaine May Benefit Breast Cancer Survivors Who Experience Dyspareunia

Breast cancer survivors with menopausal dyspareunia can have comfortable intercourse after applying liquid lidocaine.

Adding Bevacizumab to Paclitaxel Does Not Improve Survival in Angiosarcoma

Adding Bevacizumab to Paclitaxel Does Not Improve Survival in Angiosarcoma

Paclitaxel alone and paclitaxel plus bevacizumab are both active as treatments for patients with advanced angiosarcoma.

Frequent, Actionable MET Gene Mutations Found in Pulmonary Sarcomatoid Carcinoma

Frequent, Actionable MET Gene Mutations Found in Pulmonary Sarcomatoid Carcinoma

Mutational events that lead to MET exon 14 skipping may be targetable events in pulmonary sarcomatoid carcinoma (PSC).

Letrozole May Provide More Benefit in Lobular Carcinoma than Ductal Carcinoma

Letrozole May Provide More Benefit in Lobular Carcinoma than Ductal Carcinoma

Adjuvant letrozole provides more benefit to patients with lobular carcinoma compared with those with ductal carcinoma.

In Elderly Patients with Esophagogastric Adenocarcinoma, Neoadjuvant Chemo Feasible

In Elderly Patients with Esophagogastric Adenocarcinoma, Neoadjuvant Chemo Feasible

Neoadjuvant chemotherapy is feasible in elderly patients with esophagogastric adenocarcinoma.

Many Carers of Patients Newly Diagnosed with Cancer at Risk for Depression

Many Carers of Patients Newly Diagnosed with Cancer at Risk for Depression

Most carers of people with newly diagnosed cancer reported at least one unmet need and nearly a third were at risk of clinical depression.

Early Adjuvant Chemotherapy After Surgery May Reduce Risk of Relapse

Early Adjuvant Chemotherapy After Surgery May Reduce Risk of Relapse

Shorter time to initiation of adjuvant chemotherapy may reduce risk of relapse and improve clinical outcomes in breast cancer.

No Link Between Shift Work, Prostate Cancer Incidence, Study Shows

No Link Between Shift Work, Prostate Cancer Incidence, Study Shows

Late night shift work showed no link to incidence of prostate cancer in industrial workers.

Post-diagnostic Dietary Changes Among Men with Prostate Cancer Beneficial

Post-diagnostic Dietary Changes Among Men with Prostate Cancer Beneficial

General advice about diet from a qualified health professional may provide men diagnosed with prostate cancer with a focus for action.

Individualized Information Sharing Important in All Stages of Cancer Care

Individualized Information Sharing Important in All Stages of Cancer Care

Appropriate, individualized sharing of information for patients with cancer was determined to be important during all stages.

Generic Medications Boost Survival in Some Early Breast Cancers

Generic Medications Boost Survival in Some Early Breast Cancers

More evidence that two classes of generic drugs (aromatase inhibitors and bisphosphonates) reduce risk of death in early breast cancer.

Oncologists Offer Recommendations for Lowering Cost of Cancer Drugs

Oncologists Offer Recommendations for Lowering Cost of Cancer Drugs

Soaring costs for cancer drugs are detrimental to patient care in the United States, say a group of oncologists.

In End-Stage Cancer, Chemotherapy Use Doesn't Improve Quality of Life

In End-Stage Cancer, Chemotherapy Use Doesn't Improve Quality of Life

For patients with end-stage cancer, chemotherapy use does not improve quality of life near death (QOD).

miR-146a rs291064 Identified as Risk Factor for Gastric Cancer

miR-146a rs291064 Identified as Risk Factor for Gastric Cancer

Investigators found an association between miR-146a rs291064 and risk of gastric cancer (GC) development.

Understanding Financial Distress in Patients with Advanced Cancer

Understanding Financial Distress in Patients with Advanced Cancer

More than 30% of patients with advanced cancer reported more severe financial distress than physical, family, and emotional distress.

FDA Approves Kyprolis as Second-Line Treatment for Multiple Myeloma

FDA Approves Kyprolis as Second-Line Treatment for Multiple Myeloma

The FDA has granted accelerated approval for Kyprolis (carfilzomib) as second-line treatment for patients with multiple myeloma.

FDA Approves Sonidegib for Locally Advanced Basal Cell Carcinoma

FDA Approves Sonidegib for Locally Advanced Basal Cell Carcinoma

The FDA has approved sonidegib (Odomzo) for the treatment of basal cell carcinoma that has recurred following surgery or radiotherapy.

In Giant Cell Tumor of Bone, Denosumab Shows Robust Clinical Efficacy

In Giant Cell Tumor of Bone, Denosumab Shows Robust Clinical Efficacy

Denosumab has robust clinical efficacy in the treatment of patients with giant cell tumor of bone (GCTB).

KRAS Not Prognostic, Predictive of Docetaxel or Erlotinib Benefit

KRAS Not Prognostic, Predictive of Docetaxel or Erlotinib Benefit

KRAS was neither prognostic nor predictive of benefit for either docetaxel or erlotinib in non-small cell lung cancer (NSCLC).

Physicians May Underestimate Recurrence of Gastrointestinal Tumors After Resection

Physicians May Underestimate Recurrence of Gastrointestinal Tumors After Resection

For patients with resectable gastrointestinal stromal tumors (GISTs), physicians tend to underestimate risk of recurrence.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs